AI-generated summary
The authors report a systematic review and meta-analysis of 15 studies including 1097 patients with androgenetic alopecia, finding that fractional laser therapy was associated with a significant improvement in hair density compared with control interventions. Adverse events were described as mostly mild to moderate and self-resolving. The authors note that future high-quality studies are needed to confirm long-term effectiveness and optimal treatment parameters.
- Participants
- 1,097
- Studies included
- 15
- Who or what was studied
- Patients with androgenetic alopecia
- Wavelengths
- 1565, 1550, 1927 nm
- Limits stated in the abstract
- The abstract states that future high-quality studies are needed to validate long-term effectiveness and optimal treatment parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
To systematically evaluate the efficacy and safety of fractional laser therapy in the treatment of androgenetic alopecia.
Methods
A comprehensive literature search was conducted in PubMed, Web of Science, Embase, the Cochrane Library, and China National Knowledge Infrastructure (CNKI) from inception to November 2025. Eligible studies were selected according to the PICOS framework. The methodological quality of the included studies was assessed using the Cochrane Risk of Bias tool. Meta-analysis was performed using R software.
Results
A total of 15 studies involving 1097 patients were included. Meta-analysis demonstrated that fractional laser therapy significantly improved hair density compared with control interventions (mean difference [MD] = 13.88, 95% confidence interval [CI]: 6.87-20.90, p < 0.001). Subgroup analysis revealed no significant difference in efficacy between ablative and non-ablative fractional lasers (p = 0.7792), nor between different wavelengths (1565 nm, 1550 nm, 1927 nm; p = 0.7014). Combination therapy with laser and other treatments (e.g., minoxidil) showed a certain advantage over other treatments alone (MD = 9.74, p = 0.001). Adverse events were predominantly mild to moderate, including erythema, pain, and pruritus, all of which resolved spontaneously.
Conclusion
Fractional laser therapy demonstrates marked therapeutic efficacy and a favorable safety profile in the treatment of androgenetic alopecia, making it a viable clinical treatment option. Future high-quality studies are warranted to further validate its long-term effectiveness and optimal treatment parameters.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1565 nm, 1550 nm, 1927 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Androgenetic alopecia, Meta-analysis, Systematic review, Confidence interval, Risk of bias. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.